IPO
China IPOs: Onshore attraction
The valuations available on China's booming Star Market are prompting US dollar managers to consider restructuring companies for onshore listings. How long will the fervor last?
China's Li Auto gains 43% on debut after $1.1b US IPO
Chinese electric vehicle manufacturer Li Auto closed up 43% on its first day of trading on NASDAQ following a $1.1 billion IPO.
Chinese real estate platform Beike pursues US IPO
Beike, a Chinese online real estate platform backed by Tencent Holdings, SoftBank Vision Fund and Hillhouse Capital, has filed for US IPO.
SPACs: Flavor of the month
Special purpose acquisition companies (SPACs) are gaining popularity among private equity investors in Asia. While these structures have various attractive qualities, they aren't for everyone
PE-backed Cambricon becomes China's first listed AI chip maker
Beijing-based Cambricon Technology, which is backed by CICC Capital, Alibaba Group, and Lenovo, has listed on the Star Market. It is the first Chinese artificial intelligence (AI) chip manufacturer to complete an IPO.
Canyon Bridge, K2 Venture founders join Asia SPAC wave
Two more groups featuring Asian private equity executives have listed special purpose acquisition companies (SPACs) on US bourses as interest in these structures continues to rise globally.
PE-backed Junshi Biosciences shines on Star Market debut
PE-backed Junshi Biosciences has become the first Chinese biotech company to list in Hong Kong and the mainland, following a strong debut on Shanghai's Star Market.
2Q analysis: Numbers that deceive
Asia has seen remarkable revivals in private equity investment and fundraising – though not in exits – over the past three months. A handful of large-cap situations mask a weak environment
Ocumension climbs on debut after $184m Hong Kong IPO
Ocumension Therapeutics, a Chinese drug developer targeting eye diseases that counts Boyu Capital and Temasek Holdings among its backers, posted a 152% gain on debut following a HK$1.5 billion ($200 million) Hong Kong IPO.
China EV maker Li Auto pursues US listing
Li Auto, a Chinese electric vehicle manufacturer that has been backed by online-to-offline (O2O) services giant Meituan Dianping, has filed for a US IPO.
Portfolio: CBC Group and I-Mab Biopharma
CBC Group’s stewardship of I-Mab Biopharma brings an intensely hands-on platform-based approach to a booming China biotech space often characterized by relatively passive strategies
China gay dating app Blued raises $85m in US IPO
BlueCity Holdings, the VC-backed holding company for Chinese gay dating platform Blued, traded strongly after raising $84.8 million through a NASDSAQ IPO.
Korea's ACE Equity launches SPAC targeting IT infrastructure
Korean private equity firm ACE Equity Partners has taken another step in the development of its cross-border investment capabilities with the launch of a US-listed special purpose acquisition company (SPAC) to pursue IT infrastructure assets.
China IPOs: Star attraction
Having previously focused on offshore IPOs, China managers with US dollar funds are now considering the Star Market. But going onshore means more regulation as well as high valuations
China's Ucommune acquired by US-listed SPAC for $765m
Ucommune, a Chinese co-working space operator that failed to get traction with an attempted New York IPO last year, has been acquired by a US-listed special purpose acquisition company (SPAC) at a valuation of $764.9 million.
PE-backed Hygeia completes $286m Hong Kong IPO
Chinese radiotherapy business Hygeia Healthcare, which counts Warburg Pincus, Boyu Capital, and CITIC Capital among its investors, raised HK$2.22 billion ($286.4 million) in its Hong Kong IPO.
China healthcare IPOs: Good prognosis?
There has been a steady stream of China healthcare IPOs - most of them drug developers - on the domestic, Hong Kong and US bourses in recent months. They might be benefiting from a COVID-19 tailwind but it won't be permanent
China's Agora more than doubles in value after $350m US IPO
Agora.io, a real-time voice and video communication platform established by Tony Zhao, formerly CTO of Chinese social networking player YY.com, saw its stock gain 151% on its NASDAQ trading debut following a $350 million IPO.
VC-backed SinocellTech enjoys strong Star Market debut
Chinese drug developer SinocellTech nearly trebled in value on its first day of trading on China's Science and Technology Innovation Board (Star Market) following a RMB1.28 billion ($181 million) IPO.
Toshiba seeks exit from PE-controlled flash memory business
Toshiba is exploring ways to fully exit its 40.2% stake in Kioxa Holdings, two years after selling control of the Japanese flash memory division to a Bain Capital-led consortium for an enterprise valuation of JPY2 trillion ($18.7 billion).
Chinese IPOs: One less option
Will Chinese companies listed in the US become the latest casualties of tensions between the two countries? It could lead to a narrowing in IPO exit options for PE and VC investors
China's Genetron trades flat after upsizing US IPO
Genetron Holdings, a Chinese company that uses DNA sequencing to support the diagnosis and treatment of cancer, traded flat on its NASDAQ debut following a larger-than-planned $256 million IPO.
China gay dating app Blued pursues US IPO
BlueCity Holdings, the company behind Chinese gay dating platform Blued, has filed an application to list on NASDAQ, which would provide a liquidity event for several PE and VC investors.
India’s Happiest Minds Technologies files for IPO
Indian IT outsourcing company Happiest Minds Technologies, which is backed by J.P. Morgan Asset Management, has filed for an initial public offering.
